Skip to main content

Table 1 Clinical characteristics

From: Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management

Characteristic

Value

Total number of patients

25

Age (years)

 Mean± standard deviation

61± 12

 Range

34–86

Gender

 Male

14

 Female

11

Primary tumor site

 Pancreas

8

 Stomach

1

 Small bowel

6

 Neck

1

 Thymus

1

 Rectum

1

 Carotid glomus

1

 Adrenal glands

1

 Retroperitoneum

1

 Lung

2

 Unknown

2

Sites of metastases

 Liver

18

 Lymph nodes

15

 Bone

11

 Lung

1

 Peritoneum

4

 Pancreatic bed

1